Novadaq Technologies
Novadaq Technologies Inc(NVDQ.US)成立于2000年,總部位于加拿大安大略,主要從事醫學影像系統的研發、生產及銷售,包括:SPY影像系統、內視鏡螢光影像系統、機器人手術系統及心臟雷射系統,產品主要應用于整型重建外科、腹部外科、心臟外科以及一般外科等。
其中,「SPY影像系統」主要應用于乳房重建、頭頸和大腸直腸??剖中g等,協助外科醫師評估手術部位灌流不良或不足的組??織。
2009年1月,公司宣布成為「PLC Medical」公司「心臟雷射系統」在北美的獨家經銷商;同期并與「Intuitive Surgical」聯盟,將SPY影像技術及da Vinci Surgical Robotic System(達芬奇手術機器人系統)的3維HD影像功能整合一體。
2010年9月,公司與KCI旗下的「LifeCell ?」公司簽訂「SPY影像系統」北美獨家經銷協議。
Enabling surgeons with clinically-relevant, innovative fluorescence imaging solutions to enhance the lives of patients and their surgeons, while reducing health care costs, is Novadaq’s global mission. SPY fluorescence imaging technology provides surgeons with real-time visualization, leading to improved outcomes and reduced costs without exposing the patient to radiation. More than 50 peer-reviewed publications demonstrate that the use of SPY during complex surgery, leads to fewer post-operative complications and lower hospital costs.
The SPY Imaging System is United States Food and Drug Administration (“FDA”) 510(k) cleared for use for use in seven surgical specialties. The endoscopic version of SPY called PINPOINT?, combines the capabilities of SPY Imaging with high definition (“HD”) visible light visualization offered by conventional endoscopes. Our unique business model of partnering with market-leading companies to drive adoption of our fluorescence imaging technology, while building our own commercial infrastructure is the cornerstone of our corporate strategy for growth.
Novadaq is traded on the NASDAQ Stock Exchange (Sym: NVDQ) and the TSX (Sym: NDQ).